Clinical Study Results
Research Sponsor: AstraZeneca AB
Drug Studied: AZD6094
Study Title: A study to learn how a drug called AZD6094 affects the
electrical activity of the hearts of healthy volunteers
Thank you!
Thank you to the participants who took part in the clinical trial for the study drug
AZD6094.
AstraZeneca AB sponsored this study and thinks it is important to share the results. An
independent, non-profit organization called CISCRP helped prepare this summary of
the study results for you.
If you participated in the study and have questions about the results, please speak with
the doctor or staff at your study site.
What is happening with the study now?
The study started in September 2017 and ended in March 2018. The study included
45 participants in the United States.
The sponsor reviewed the data collected when the study ended and created a report
of the results. This is a summary of that report.
1